Book contents
- Clinical and Diagnostic Virology
- Reviews
- Clinical and Diagnostic Virology
- Copyright page
- Contents
- Preface
- Acknowledgements
- Abbreviations
- Introduction
- Section 1 Individual Viruses
- Section 2 Other Related Agents
- Section 3 Clinical Syndromes
- Section 4 Laboratory Diagnosis
- Section 5 Patient Management
- Chapter 54 Antiviral Drugs
- Chapter 55 Viral Vaccines
- Chapter 56 Infection Control
- Chapter 57 Occupational Health
- Chapter 58 Public Health and Pandemic Preparedness
- Index
Chapter 54 - Antiviral Drugs
from Section 5 - Patient Management
Published online by Cambridge University Press: 11 April 2024
- Clinical and Diagnostic Virology
- Reviews
- Clinical and Diagnostic Virology
- Copyright page
- Contents
- Preface
- Acknowledgements
- Abbreviations
- Introduction
- Section 1 Individual Viruses
- Section 2 Other Related Agents
- Section 3 Clinical Syndromes
- Section 4 Laboratory Diagnosis
- Section 5 Patient Management
- Chapter 54 Antiviral Drugs
- Chapter 55 Viral Vaccines
- Chapter 56 Infection Control
- Chapter 57 Occupational Health
- Chapter 58 Public Health and Pandemic Preparedness
- Index
Summary
This chapter provides an overview of the antiviral drugs currently available, including maraviroc, aciclovir, penciclovir, ganciclovir, amantadine, zydovudine, adefovir, ribavirin, indinavir , oseltamivir, zanamivir, interferon alpha, rituximab , palivizumab, cidofovir, brincidofovir, foscarnet, remdesivir and paxlovid with an indication of their modes of action for treating virus infections, including HIV, herpes viruses, respiratory viruses, HBV, HCV, CMV, adenoviruses , BK, EBV (especially for PTLD), RSV, poxviruses and SARS-CoV-2.
Keywords
- Type
- Chapter
- Information
- Clinical and Diagnostic Virology , pp. 263 - 273Publisher: Cambridge University PressPrint publication year: 2024